Shares of RXO, Inc. (NYSE:RXO – Get Free Report) have been assigned an average rating of “Hold” from the fifteen research firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $26.77.
A number of research analysts recently issued reports on RXO shares. Oppenheimer reiterated an “outperform” rating and set a $31.00 target price on shares of RXO in a research report on Tuesday, September 17th. Citigroup lowered shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 price objective on the stock. in a report on Tuesday, November 12th. Wells Fargo & Company reduced their target price on RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 7th. Susquehanna cut their price target on RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a report on Tuesday, November 12th. Finally, Jefferies Financial Group decreased their price objective on RXO from $33.00 to $30.00 and set a “buy” rating for the company in a report on Friday.
Check Out Our Latest Analysis on RXO
RXO Stock Performance
RXO (NYSE:RXO – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The business had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $956.19 million. During the same quarter last year, the firm posted $0.05 earnings per share. The firm’s revenue was up 6.6% on a year-over-year basis. As a group, analysts anticipate that RXO will post 0.12 EPS for the current year.
Institutional Trading of RXO
Several institutional investors have recently made changes to their positions in RXO. GAMMA Investing LLC boosted its holdings in RXO by 40.0% during the third quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after purchasing an additional 510 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after buying an additional 570 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of RXO by 2.3% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 25,537 shares of the company’s stock worth $668,000 after buying an additional 575 shares during the last quarter. Glenmede Trust Co. NA grew its holdings in shares of RXO by 4.9% in the third quarter. Glenmede Trust Co. NA now owns 13,923 shares of the company’s stock valued at $390,000 after acquiring an additional 650 shares in the last quarter. Finally, Arizona State Retirement System increased its position in shares of RXO by 2.3% during the second quarter. Arizona State Retirement System now owns 32,906 shares of the company’s stock valued at $860,000 after acquiring an additional 751 shares during the last quarter. Institutional investors own 92.73% of the company’s stock.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Stories
- Five stocks we like better than RXO
- Manufacturing Stocks Investing
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Ride Out The Recession With These Dividend Kings
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.